<DOC>
	<DOCNO>NCT01371877</DOCNO>
	<brief_summary>This clinical study design base hypothesis vitamin D play important role chronic urticaria high dose supplementation vitamin D subject chronic urticaria improve clinical response . This clinical study investigate hypothesis three Specific Aims : 1 . Determine whether high dose vitamin D supplementation ( 4000 IU/day ) reduce medication usage ( primary outcome ) urticaria severity score ( secondary outcome ) subject chronic urticaria compare low dosing ( 600 IU/day ) . 2 . Determine high dose vitamin D ( 4000 IU/day ) safe well-tolerated subject chronic urticaria without baseline vitamin D deficiency . 3 . Investigate whether association serum 25-hydroxyvitamin D level , vitamin D receptor mRNA expression , chronic urticaria severity .</brief_summary>
	<brief_title>The Role Vitamin D Chronic Urticaria Angioedema Treatment</brief_title>
	<detailed_description>The purpose pilot , 12 week , clinical research study determine supplementation Vitamin D improve clinical outcome subject chronic urticaria angioedema ( CUA ) . Vitamin D key element regulation immune system response , vitamin D could play important role treatment CUA . Recently , publish important association CUA serum 25-hydroxy vitamin D ( 25OHD ) . Namely , vitamin D level subject CUA significantly low compare subject alternative allergic disorder , allergic rhinitis . There one observational report supplementation vitamin D ( 50,000/wk ) subject CUA result clinical improvement ; however , one treatment arm optimal serum 25OHD require obtain benefit investigate . This current study double-blinded , prospective , interventional study seek recruit adult subject physician-diagnosed CUA randomize subject either recommend dietary allowance ( Vitamin D 600 IU/day ) recommend upper limit intake ( Vitamin D 4000 IU/day ) . Subjects answer questionnaire collect information regard demographic , previous diagnostic test , medication , complete urticaria severity score ( USS ) . Information medical record : weight , height , body mass index ( BMI ) , thyroid stimulate hormone ( TSH ) , free thyroxine ( T4 ) , thyroid autoantibody , urticaria autoimmune test ( CD203c result ) , anti-nuclear antibody ( ANA ) , urinalysis , allergy skin prick testing , part CUA evaluation obtain . Subjects research blood draw serum 25OHD level , iPTH , calcium , phosphorus , albumin , urine calcium , vitamin D receptor ( VDR ) gene expression . All subject receive standard-of-care therapy accord 2009 Third International Consensus Meeting Urticaria position guideline . Follow-up visit medication usage , urticaria severity score , serum urine safety monitor 6 12 week . The hypothesis study high dose vitamin D result clinical improvement subject CUA . The primary clinical endpoint medication usage , secondary outcome urticaria severity score prednisone rescue use . We explore threshold serum 25OHD level correlate VDR expression correlate clinical outcome , determine power analysis conduct large scale study . Finally , study aim determine vitamin D supplementation safe well-tolerated subject CUA .</detailed_description>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Subjects include physiciandiagnosed chronic urticaria and/or angioedema ( CUA ) . CUA define urticarial wheal ( hive ) and/or angioedema ( dermal swell ) daily almost daily 6 week . Patients CUA also sign dermatographism and/or delayedpressure urticaria include study . Subjects history intolerance nonsteroidal antiinflammatory drug include warned take drug class ( acetaminophen allow instead ) . Subjects exclude : 1 . They capable answer questionnaire . 2 . Subjects pure physical allergic urticaria , and/or hereditary acquire angioedema ( C1 esterase inhibitor deficiency ) . These subject exclude etiology disease know . 3 . Pregnant lactating woman . All childbearing woman ask ( verbally questionnaire ) pregnant lactating . If answer yes , exclude . As risk harm pregnant lactate woman , urine pregnancy test use . 4 . Subjects clinically significant abnormality biochemistry test , and/or hypercalcemia ( calcium &gt; 10.3 mg/dl ) renal insufficiency ( GFR &lt; 50 ml/min ) . 5 . Subjects history primary hyperparathyroidism , renal tubular acidosis , sarcoidosis , granulomatous disease , malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>urticaria</keyword>
	<keyword>angioedema</keyword>
	<keyword>hive</keyword>
	<keyword>swell</keyword>
</DOC>